Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-controlled perimetry can reliably measure functional changes near areas of atrophy and whether this testing can be implemented in everyday clinic care over 24 months. Participants will undergo repeated vision testing, standard eye imaging, and visual function questionnaires while continuing their prescribed treatment.

NCT Number	NCT07582042
Lead Sponsor	University of Utah Collaborators: Apellis Pharmaceuticals, Inc.
Conditions	Geographic Atrophy From Age-related Macular Degeneration
Enrollment	50 participants
Start Date	2026-06-15
Primary Completion	2029-05-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-17